SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-051048
Filing Date
2020-09-17
Accepted
2020-09-17 19:20:01
Documents
1
Period of Report
2020-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4546
  Complete submission text file 0001209191-20-051048.txt   6016
Mailing Address 222 MERCHANDISE MART PLAZA SUITE 2024 CHICAGO IL 60654
Business Address
THURMAN RANDY H (Reporting) CIK: 0001204059 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37759 | Film No.: 201182338

Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)